Grand Pharmaceutical Group Limited 0512
HKEX · Hong Kong SAR China · Health Technology
HKD 4.93+0.08 (+1.65%)
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Nexalin Technology (NXL) signed an agreement to appoint Inovanexa Medical Technologies as its exclus
Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.
Daiichi Sankyo Company has seen its share price fall over the past few years, so the key issue now is whether the current market value lines up with the cash the business is expected to generate. With investors also weighing fresh data around its cancer portfolio, the question is how much of that potential is already reflected in the price you see today. Over the past 3 years the stock has declined 27.6%, which puts the focus squarely on whether the underlying cash flows still support...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.